3,4-methylenedioxyamphetamine has been researched along with African Lymphoma in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNamara, YM | 1 |
| Cloonan, SM | 1 |
| Knox, AJ | 1 |
| Keating, JJ | 1 |
| Butler, SG | 1 |
| Peters, GH | 1 |
| Meegan, MJ | 1 |
| Williams, DC | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and African Lymphoma
| Article | Year |
|---|---|
Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; D | 2011 |